<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00910260</url>
  </required_header>
  <id_info>
    <org_study_id>0000</org_study_id>
    <nct_id>NCT00910260</nct_id>
  </id_info>
  <brief_title>Impact on UVB Narrow Band and UVA1 Therapy on Serum 25-hydroxyvitamin D Levels</brief_title>
  <official_title>Impact on UVB Narrow Band and UVA1 Therapy on Serum 25-hydroxyvitamin D Levels</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We plan to investigate the serum elevation of 25(OH)D under UVB nb and UVA1 therapy, in order&#xD;
      to determine the effect of these nowadays frequently used wavelengths for phototherapy on&#xD;
      vitamin D plasma levels. We hope for a better understanding of steady-state and&#xD;
      treatment-induced levels of vitamin D changes to better recognize the impact of phototherapy&#xD;
      on vitamin D synthesis in the skin, the dimension of vitamin D production to be expected in&#xD;
      the course of standard phototherapy and a potential gap in vitamin D production compared to&#xD;
      physiological needs which then should be supplemented orally.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an open observational study in dermatological patients undergoing phototherapy.&#xD;
&#xD;
      In patients with a skin disease and the routinely given indication for a phototherapy with&#xD;
      UVB narrow-band (UVB nb, 311nm) or UVA1 (340-400 nm), the serum 25-hydroxyvitamin D, calcium,&#xD;
      parathormone, phosphate and albumin levels will be measured before, during and after&#xD;
      completion of the 12-week therapy (30 patients per group). Patients will be recruited in the&#xD;
      department of dermatology of the University Hospital ZÃ¼rich in the outpatient clinic.&#xD;
      Following oral and written consent, serum 25-hydroxyvitamin D, calcium, parathormone,&#xD;
      phosphate and albumin levels will be measured before the therapy, one week after start as&#xD;
      well as after completion of the UVB nb/UVA1 therapy.&#xD;
&#xD;
      In parallel to the study the patients will be asked to fill in a questionnaire evaluating the&#xD;
      daily vitamin D consume (milk and milk products, fish, food enhanced in vitamin D,&#xD;
      multivitamin supplements), sun exposure per week during previous weeks, degree of tanning,&#xD;
      the use of sunscreen, the DLQI and Skindex-29.&#xD;
&#xD;
      A physical examination including clinical score where available will be performed at every&#xD;
      &quot;checkpoint&quot;. During the first physical examination the Fitzpatrick-skin type of patient will&#xD;
      be recorded.&#xD;
&#xD;
      The following participant characteristics will be recorded: age, weight, body mass index&#xD;
      (BMI), phototype, skin disease, comorbidities, usual medication, and period of the year where&#xD;
      UVB nb/UVA1 therapy is performed (summer vs. winter), cumulative UVB nb/UVA1 doses.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">February 2011</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Determination of baseline serum 25-hydroxyvitamin D, calcium, parathormone, phosphate and albumin levels before therapy</measure>
    <time_frame>6 Months</time_frame>
  </primary_outcome>
  <enrollment type="Actual">116</enrollment>
  <condition>Skin Disease</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Blood analysis</intervention_name>
    <description>Serum 25-hydroxyvitamin D, calcium, parathormone, phosphate, C-reactive protein and albumin levels will be measured at every visit: day 0, day 7 and day 84.</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        dermatology clinic&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          1. Dermatological indication for a phototherapy with UVB nb or UVA1&#xD;
&#xD;
          2. Oral and written informed patient consent&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          1. Interruption of the light therapy for more than 14 days&#xD;
&#xD;
          2. Withdrawal of consent to participate&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>01 Studienregister MasterAdmins</last_name>
    <role>Study Director</role>
    <affiliation>UniversitaetsSpital Zuerich</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dermatology Department, University Hospital</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <study_first_submitted>April 17, 2009</study_first_submitted>
  <study_first_submitted_qc>May 28, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 29, 2009</study_first_posted>
  <last_update_submitted>May 18, 2014</last_update_submitted>
  <last_update_submitted_qc>May 18, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 20, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>vitamin D level under phototherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Skin Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

